Muscle, and Neuromuscular Junction Diseases During COVID-19 Pandemic: What Should We Know

Ghaydaa Shehata, A.

Department of Neurology and Psychiatry, Assuit University Hospitals, Assuit, Egypt

Dr. Ghaydaa Shehata, A., Department of Neurology and Psychiatry, Assuit University Hospitals, Assuit, Egypt.

Keywords: COVID-19; Neurology; Clinical Features; Coronavirus; Muscle Disease; Myasthenia Gravis; Myositis

Abstract

Background
A New detected virus called COVID-19 reported by World Health Organization (WHO) as pandemic at March 2020 COVID-19 is affected mainly by respiratory illness, but it can also affect the brain. Neurological manifestations are recorded COVID-19 pandemics but are not effectively addressed how to deal and treat them.
Method
In this review, I try to discuss the postulated neuronal mechanisms of the coronavirus infection sequelae. After made midlines about this topic, I discuss prevalence, pathogenesis, and then put a proposal on how to deal with muscle disease, neuromuscular junctions’ disorders.

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).